Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04635826

The Role of Expectancy for Cognitive Enhancement in College Students Using Prescription Stimulants Nonmedically

Status
Withdrawn
Phase
Phase 4
Study type
Interventional
Enrollment
0 (actual)
Sponsor
University of Alabama at Birmingham · Academic / Other
Sex
All
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

We propose to evaluate the interaction between expectations of receiving stimulants, neurophysiological activity and enhancement of cognitive performance using fMRI.

Detailed description

Participants will then be randomized in a balanced placebo design (BPD) crossing medication (10 mg of mixed amphetamine salts vs placebo) and expectancy (told active medication vs placebo medication), resulting in 4 different conditions 1) mixed amphetamine salts/told stimulant medication; 2) placebo/told stimulant medication; 3) mixed amphetamine salts/told placebo; and 4) placebo/told placebo). Participants will be assigned to four scanning sessions scheduled one week apart and will experience each condition once counterbalanced across participants. Participants will be administered cognitive tasks in and out of the scanner to determine the effects of medication vs expectancy.

Conditions

Interventions

TypeNameDescription
DRUGAdderall 10Mg TabletParticipants will be administered Adderall
DRUGPlaceboParticipants will be administered placebo

Timeline

Start date
2025-07-01
Primary completion
2029-07-31
Completion
2030-07-31
First posted
2020-11-19
Last updated
2025-04-07

Regulatory

Source: ClinicalTrials.gov record NCT04635826. Inclusion in this directory is not an endorsement.